AnalystsBill MaughanBill Maughan's Stock Forecasts
AnalystsBill Maughan
Sectors:
Industries:
Analyst Ranking
Top 34%
#1572 out of 4705 analysts
Average Return
+8.74%
Win Rate
58%7 out of 12
Risk vs Reward
Poor
Good
Bill Maughan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +143.39% | $21.94 | $53.40 | 2023-11-02 - 2024-10-11 | Strong Buy |
Y Mabs Therapeutics IncYMAB | +34.01% | $10.82 | $14.50 | 2024-08-13 - 2024-10-11 | Strong Buy |
Biontech SeBNTX | +32.09% | $91.24 | $120.52 | 2024-02-20 - 2024-10-11 | Strong Buy |
Biontech SeBNTX | +31.01% | $91.99 | $120.52 | 2024-03-21 - 2024-10-11 | Strong Buy |
Biontech SeBNTX | +29.95% | $92.74 | $120.52 | 2024-02-21 - 2024-10-11 | Strong Buy |
Bill Maughan Analyst Color
Get additional color on Bill Maughan's coverage of popular stocks
Bill Maughan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Y Mabs Therapeutics IncYMAB | 2 | Strong Buy | $26.00 | +79.31% | Maintains | 2 months ago |
Nkarta IncNKTX | 2 | Strong Buy | $15.00 | +285.60% | Maintains | 5 months ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $9.00 | +191.26% | Maintains | 5 months ago |
Immunocore Holdings PLCIMCR | 3 | Hold | $67.00 | +115.50% | Maintains | 5 months ago |
Moderna IncMRNA | 3 | Hold | $106.00 | +81.85% | Maintains | 5 months ago |
Biontech SeBNTX | 4 | Strong Buy | $171.00 | +41.89% | Reiterates | 7 months ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $24.00 | +1,448.39% | Maintains | 7 months ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | +126.76% | Reiterates | 8 months ago |
Merus NvMRUS | 1 | Strong Buy | $45.00 | -15.73% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.